In the present study, MMP-2 and MMP-9 activities have been determined in CSF and plasma samples, allowing to us to obtain novel results which can be added to those of the few studies determining the MMPs activities/levels in both the plasma and CSF of AD patients [62,63]. This evidence concerns the gene MMP9 and Alzheimer disease.